RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$7.45B
1-Year Est. Return
42.53%
1 Year Est. Return
+42.53%
AUM
$7.45B
AUM Growth
+$1.23B
(+20%)
Holding
84
Top Buys
| 1 | +$117M | |
| 2 | +$86.6M | |
| 3 | +$86M | |
| 4 |
Enovis
ENOV
|
+$83.4M |
| 5 |
Newell Brands
NWL
|
+$68.1M |
Top Sells
| 1 | +$384M | |
| 2 | +$276M | |
| 3 | +$84.8M | |
| 4 |
Adaptive Biotechnologies
ADPT
|
+$72.9M |
| 5 |
COOP
Mr. Cooper
COOP
|
+$50.4M |
Sector Composition
| 1 | Healthcare | 36.98% |
| 2 | Utilities | 25% |
| 3 | Industrials | 15.36% |
| 4 | Energy | 6.88% |
| 5 | Financials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Enovis
ENOV
$1.68B
| $83.4M | 0.94% |
+2,750,000
|
|
||
27
Zymeworks
ZYME
$1.96B
| $80.5M | 0.91% |
4,710,551
|
|
||
28
Trevi Therapeutics
TRVI
$1.71B
| $78.1M | 0.88% |
8,531,860
|
|
||
29
Cimpress
CMPR
$1.67B
| $74.4M | 0.84% |
1,180,789
+619,360
|
|
||
30
Opko Health
OPK
$1.01B
| $74.1M | 0.84% |
47,791,243
|
|
||
31
Adeia
ADEA
$1.36B
| $72M | 0.81% |
4,284,205
|
|
||
|
32
Newell Brands
NWL
$1.6B
| $68.1M | 0.77% |
+13,000,000
|
|
||
33
Telephone and Data Systems
TDS
$4.57B
| $62.8M | 0.71% |
+1,600,000
|
|
||
34
MannKind Corp
MNKD
$1.67B
| $61.3M | 0.69% |
+11,414,671
|
|
||
35
The GEO Group
GEO
$2.25B
| $61.2M | 0.69% |
2,986,915
+1,739,522
|
|
||
36
Protolabs
PRLB
$1.18B
| $56.2M | 0.63% |
1,123,338
+89,167
|
|
||
37
New Fortress Energy
NFE
$373M
| $54.7M | 0.62% |
24,767,087
+367,087
|
|
||
38
Orthofix Medical
OFIX
$628M
| $54.5M | 0.61% |
3,721,715
|
|
||
39
Liberty Global Class C
LBTYK
$3.84B
| $53.3M | 0.6% |
4,538,570
+1,248,781
|
|
||
40
ARS Pharmaceuticals
SPRY
$929M
| $45.2M | 0.51% |
4,500,000
+3,205,122
|
|
||
41
Mativ Holdings
MATV
$673M
| $45M | 0.51% |
3,982,442
|
|
||
42
CoreCivic
CXW
$1.88B
| $39.9M | 0.45% |
1,961,446
+1,146,166
|
|
||
43
Alight
ALIT
$1.23B
| $37.2M | 0.42% |
11,398,583
-8,228,370
|
|
||
44
Heron Therapeutics
HRTX
$211M
| $36.7M | 0.41% |
29,100,728
+2,387,225
|
|
||
|
MREO
45
Mereo BioPharma
MREO
$293M
| $31.5M | 0.36% |
15,307,347
|
|
||
46
ANI Pharmaceuticals
ANIP
$1.9B
| $31.5M | 0.35% |
343,414
+85,745
|
|
||
47
MeiraGTx Holdings
MGTX
$631M
| $30.7M | 0.35% |
3,726,451
|
|
||
|
SCPH
48
DELISTED
scPharmaceuticals
SCPH
| $28.9M | 0.33% |
5,101,886
+499,909
|
|
||
49
Supernus Pharmaceuticals
SUPN
$2.56B
| $28.5M | 0.32% |
595,366
-99,673
|
|
||
50
Indivior
INDV
$4.2B
| $27.3M | 0.31% |
1,130,961
-3,516,218
|
|